Literature DB >> 1738189

Soft-laser therapy for iatrogenic mucositis in cancer patients receiving high-dose fluorouracil: a preliminary report.

N Pourreau-Schneider, M Soudry, J C Franquin, H Zattara, P M Martin, G Ciais, M Namer, M Schneider, P Chauvel, F Demard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1738189     DOI： 10.1093/jnci/84.5.358

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer.

Authors:  F G Jansman; D T Sleijfer; J C de Graaf; J L Coenen; J R Brouwers
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  [The therapeutic management of radiogenic oral mucositis].

Authors:  W Dörr; I Dölling-Jochem; M Baumann; T Herrmann
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

3.  Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.

Authors:  Ajay Prashad Gautam; Donald J Fernandes; Mamidipudi S Vidyasagar; Arun G Maiya; Shantling Nigudgi
Journal:  Support Care Cancer       Date:  2012-12-08       Impact factor: 3.603

4.  The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies.

Authors:  M T Genot-Klastersky; J Klastersky; F Awada; A Awada; P Crombez; M D Martinez; M F Jaivenois; M Delmelle; G Vogt; N Meuleman; M Paesmans
Journal:  Support Care Cancer       Date:  2008-05-06       Impact factor: 3.603

Review 5.  Cancer therapy and oral mucositis. An appraisal of drug prophylaxis.

Authors:  C J Verdi
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.